Dr. Reddy's Laboratories Ltd.

₹1234.6

Dr. Reddy's Laboratories Ltd.

Add Alert
Add Watchlist

₹1234.6

₹1234.6

-18.5 (-1.48%) - 29 Sep 2025 04:26 PM

About Company

Dr. Reddy’s Laboratories is a multinational pharmaceutical company that manufactures and markets a wide range of pharmaceutical products and services. Through its businesses - Pharmaceutical Services and Active Ingredients, Global Generics and Proprietary Products - the Company offers a portfolio of products and services, including Active Pharmaceutical Ingredients (APIs), Custom Pharmaceutical Services (CPS), generics, biosimilars and differentiated formulations. The company offers a portfolio of products and services including APIs, generics, branded generics, biosimilars and OTC. Its major therapeutic areas of focus are gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Its major markets include – USA, India, Russia & CIS countries, China, Brazil and Europe. 

Market Cap. ₹ 103,041 Cr.
52 Week - High/Low ₹ 1,421/1,020
P/E Ratio 14.94
P/B Ratio 3.57
Enterprise Value ₹ 102,847 Cr.
ROE % 20.25
RSI Value 36.52
EMA 50 1274.12
EMA 200 1253.2
Market Cap. ₹ 103,041 Cr.
52 Week - High/Low ₹ 1,421/1,020
P/E Ratio 18.13
P/B Ratio 3.07
Enterprise Value ₹ 101,214 Cr.
ROE % 18.61
RSI Value 36.52
EMA 50 1274.12
EMA 200 1253.2

Valuation

Calculators

Peer Comparison

Industry - Pharmaceuticals & Drugs

* Please refer to the Standalone data if Consolidated financial data for the company is not available.

Shareholding Pattern Numbers in percentages

Insight market
Copyright © 2025 All rights reserved with INVESMATE INSIGHTS PRIVATE LIMITED | All logos and Trademarks registered with their respective owners.